Engineers Gate Manager LP

Position in PTGX — Protagonist Therapeutics, Inc

CIK 1620220 NEW YORK, NY

Position in PTGX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$536,042

-$205,171 QoQ

Shares Held

4,373

-71.5% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#209

of 343 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Engineers Gate Manager LP holds $195,980,910 across 162 Biotechnology names. PTGX ranks #85 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	126,044	$13,438,811
2	BMRN	Biomarin Pharmaceutical Inc	181,647	$10,393,841
3	ALNY	Alnylam Pharmaceuticals, Inc.	33,469	$10,075,173
4	REGN	Regeneron Pharmaceuticals, Inc.	15,918	$9,925,509
5	RPRX	Royalty Pharma plc	137,994	$7,737,323
6	EXEL	Exelixis, Inc.	110,353	$6,004,306
7	ONC	BeOne Medicines Ltd.	16,302	$4,645,580
8	VERA	Vera Therapeutics, Inc.	108,139	$4,640,244

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$536,042	4,373	-71.5%	Shares	Sole	2026-08-14
2025-03-31	$741,213	15,327	+20.6%	Shares	Sole	2025-05-15
2024-06-30	$440,297	12,707	-66.2%	Shares	Sole	2024-08-14
2024-03-31	$1,086,900	37,570	+200.0%	Shares	Sole	2024-05-15
2023-12-31	$287,129	12,522	-51.6%	Shares	Sole	2024-02-14
2023-09-30	$431,244	25,854	+178.7%	Shares	Sole	2023-11-14
2023-03-31	$213,394	9,278	-38.9%	Shares	Sole	2023-05-15
2022-12-31	$165,701	15,188	+33.4%	Shares	Sole	2023-02-14
2022-06-30	$90,039	11,383	-79.9%	Shares	Sole	2022-08-15
2022-03-31	$1,344,147	56,763	+1105.2%	Shares	Sole	2022-05-16
2021-06-30	$211,384	4,710	-63.9%	Shares	Sole	2021-08-16
2020-12-31	$262,684	13,030	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.